Hugemed key facts
as of Oct 2026- Developer and manufacturer of medical devices intended to support clinical surgeries.
- Hugemed is valued at approximately $351.9M as of Oct 2026 (last reported valuation).
- It has raised $22.4M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Shenzhen Capital Group, Qiming Venture Partners, C&D Emerging Investment, Shenzhen Credit Guarantee Group, Fengnian Capital — 7 tracked in total.
- Status: Privately Held (backing).
Hugemed's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·Watch Hugemed: the Monday email on marks, rounds and moves
Hugemed funding rounds
No funding rounds for Hugemed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Hugemed valuation
Hugemed's last reported valuation was $352 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Hugemed investors
7 investors are on record for Hugemed, including Shenzhen Capital Group, Qiming Venture Partners, C&D Emerging Investment and Shenzhen Credit Guarantee Group.
About Hugemed
Developer and manufacturer of medical devices intended to support clinical surgeries. The company's devices provide solutions in the field of endoscopy for clinical surgery, emergency, anesthesia, respiratory, pediatrics, ICU, operating room, ambulance, outdoor emergency, and other medical use cases, enabling healthcare providers to leverage disposable endoscopes for emergency cases.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2014
- Employees
- 216
- Website
- hugemed.net/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.